PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE

Gene dosage of the apolipoprotein E (APOE) epsilon 4 allele is a major risk factor for familiar Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects and 24 3 controls as well as 150 affected and 197 unaffected members of 66 AD families. Our data demonstrate a protective effect of the epsilon 2 a llele, in addition to the dose effect of the epsilon 4 allele in spora dic AD. Although a substantial proportion (65%) of AD is attributable to the presence of epsilon 4 alleles, risk of AD is lowest in subjects with the epsilon 2/epsilon 3 genotype, with an additional 23% of AD a ttributable to the absence of an epsilon 2 allele. The opposite action s of the epsilon 2 and epsilon 4 alleles further support the direct in volvement of APOE in the pathogenesis of AD.